步长制药：补选独立董事

Core Viewpoint - The company, Buchang Pharmaceutical (603858), announced the nomination of Song Xiayun and Chen Zhanming as independent director candidates for its fifth board of directors [1] Group 1 - The board of directors of Buchang Pharmaceutical has approved the nomination of two independent director candidates [1]